Details
| Original language | English |
|---|---|
| Pages (from-to) | 10-16 |
| Number of pages | 7 |
| Journal | Journal of cystic fibrosis |
| Volume | 17 |
| Issue number | 1 |
| Publication status | Published - 9 Dec 2017 |
Keywords
- Drug screening, Ethics, Gene editing, iPS cells, Stem cells
ASJC Scopus subject areas
- Medicine(all)
- Pediatrics, Perinatology, and Child Health
- Medicine(all)
- Pulmonary and Respiratory Medicine
Cite this
- Standard
- Harvard
- Apa
- Vancouver
- BibTeX
- RIS
In: Journal of cystic fibrosis, Vol. 17, No. 1, 09.12.2017, p. 10-16.
Research output: Contribution to journal › Review article › Research › peer review
}
TY - JOUR
T1 - Gene editing & stem cells
AU - Harrison, Patrick T.
AU - Hoppe, Nils
AU - Martin, Ulrich
N1 - Funding information: The authors wish to thank Sylvia Hafkemeyer (Mukoviszidoze e.V.), Veronique Marguerite (VLM), Vincent Gulmans (NCFS), Janet Allen (CF Trust), David Debisschop (ECFS), and Christine Dubois (ECFS) for the initiative and organization of the meeting. Work in the authors labs has been supported by CF Foundation and CF Trust (PTH), the Cluster of Excellence REBIRTH (NH, UM), the German Center for Lung Research, E-RARE and MUKO e.V. (UM).
PY - 2017/12/9
Y1 - 2017/12/9
KW - Drug screening
KW - Ethics
KW - Gene editing
KW - iPS cells
KW - Stem cells
U2 - 10.1016/j.jcf.2017.11.018
DO - 10.1016/j.jcf.2017.11.018
M3 - Review article
C2 - 29233638
AN - SCOPUS:85037626528
VL - 17
SP - 10
EP - 16
JO - Journal of cystic fibrosis
JF - Journal of cystic fibrosis
SN - 1569-1993
IS - 1
ER -